On May 2, the Cabinet announced that price control measures for medications would be implemented. This has generated a flurry of reactions from the pharmaceutical industry, private hospitals, civil society and consumers. We try to understand the issue with the help of Azrul Mohd Khalib, CEO, Galen Centre for Health & Social Policy and Dr June Choon, Lecturer in Pharmaceutical Sciences, who specialises in health economics.

Produced by: Tee Shiao Eek

Presented by: Tee Shiao Eek

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Politics,  Law and Legal Matters,  Health Policy,  Diseases and Conditions,  Mental Health,  Healthy Living,  Fitness,  Science,  Business Analysis,  Trends and Forecasts,  Markets,  Social Issues,  Medical Innovation and Technology

Tags:  The Bigger Picture,  Health and Living,  medicine,  drugs,  price,  healthcare costs,  pharmaceutical,  pharmacist,